Beam Therapeutics
BEAM
#3964
Rank
$3.22 B
Marketcap
$31.30
Share price
-1.42%
Change (1 day)
71.60%
Change (1 year)

Revenue for Beam Therapeutics (BEAM)

Revenue in 2026 (TTM): $0.16 Billion USD

According to Beam Therapeutics 's latest financial reports the company's current revenue (TTM ) is $0.16 Billion USD. In 2025 the company made a revenue of $0.13 Billion USD an increase over the revenue in the year 2024 that were of $63.51 Million USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Beam Therapeutics from 2019 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) $0.16 B17.37%
2025 $0.13 B120.01%
2024 $63.51 M-83.18%
2023 $0.37 B520.01%
2022 $60.92 M17.51%
2021 $51.84 M215916.67%
2020 $0.02 M33.33%
2019 $0.01 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ORIC Pharmaceuticals
ORIC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA